PERSPECTA

News from every angle

Back to headlines

Egypt’s Minapharm Secures $16.5 Million to Develop New Ebola Vaccine

The Egyptian pharmaceutical company Minapharm has received significant funding to advance research and production of a novel vaccine targeting the ongoing Ebola outbreak.

28 Aug, 10:17 — 28 Aug, 10:17
PostShare